PF-06821497

PF-06821497 Uses, Dosage, Side Effects, Food Interaction and all others data.

PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma).

Trade Name PF-06821497
Generic PF-06821497
Type
Formula C22H24Cl2N2O5
Weight Average: 467.34
Monoisotopic: 466.1062273
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
PF-06821497
PF-06821497

Innovators Monograph

You find simplified version here PF-06821497

*** Taking medicines without doctor's advice can cause long-term problems.
Share